… studies provide a platform for more detailed studies into the PINK1-parkin pathway. This proposal involves … reagents termed monoclonal antibodies that should help the research community uncover greater information on the … and Neuromab against the total PINK1 protein. Relevance to Diagnosis/Treatment of Parkinson’s Disease: We hope that the …

… PD Patients, members of the MJFF research community and Team Fox superstars gathered for a photo shoot in Boston on Friday. It was an amazing day in which …

… NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced today the launch of its 2007 … seeks out proposals that stimulate well-designed clinical research projects focused on potentially high-impact … delivery of promising therapies to patients and enabling researchers to bridge the gap between lab results and …

… 13, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded the 2017 Robert A. Pritzker … function visualized in specialized brain scans as an early marker of the disease. In addition to serving as … research funders; increases the flow of participants into Parkinson's disease clinical trials with its online …

… reagents called monoclonal antibodies that should help the research community understand LRRK1 function. This will help … on LRRK1/LRRK2 and Parkinson’s disease. Relevance to Diagnosis/Treatment of Parkinson’s Disease : We hope that the LRRK1 antibodies will be useful to researchers as well as pharmaceutical companies who are …

… The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced today that it has awarded nine grants totaling nearly $4.4 million to researchers pursuing the development of a cell line …